Interbody Fusion Implant Fully Integrates with Vertebral Bodies
|
By HospiMedica International staff writers Posted on 06 Nov 2018 |
|
Image: The ENZA-A Titanium ALIF system (Photo courtesy of Camber Spine Technologies).
A new minimally invasive anterior lumbar interbody fusion (ALIF) device provides support and integrated fixation.
The Camber Spine Technologies (Wayne, PA, USA) ENZA-A Titanium ALIF system is an interbody fusion device indicated for use with autogenous bone graft in patients suffering from degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. The implants may be placed via a laparoscopic or an open anterior approach, and feature two anchor plates—housed within the three-dimensional (3D) printed titanium body—that are deployed into adjacent vertebrae to provide fixation. The use of supplementary fixation systems is also recommended.
ENZA-A Titanium ALIF has a roughened surface texture designed to encourage bone growth onto the cranial and caudal surfaces of the device. The upper and lower facets are deliberately designed with pores that average a large 500 microns in diameter, the optimal environment for bone ingrowth. In addition, the implant has multiple openings that allow large volumes of autogenous bone graft to be easily packed inside, further facilitating fusion. Proprietary inline instrumentation is used to insert the device, deploy the anchor plates, and lock it in place.
“ENZA-A leverages two of Camber Spine's highly innovative platform technologies,” said Daniel Pontecorvo, CEO of Camber Spine Technologies. “The vast interest and success of our first generation ENZA with Duo Presa anchor technology and our line of SPIRA products with Surface By Design inspired us to combine their defining attributes to create this next generation ENZA-A Titanium ALIF.”
Interbody devices are designed to replace the intervertebral disc of the spine, enhancing stability in the region while the spine fuses. Over time, the packed bone graft material is gradually replaced by natural bone. Fusion procedures also typically use a posterior fixation device to the associated level, since the surgeons will implant interbody devices from an anterior approach and flip the patient over to implant a posterior pedicle screw device. This combination increases fusion success.
Related Links:
Camber Spine Technologies
The Camber Spine Technologies (Wayne, PA, USA) ENZA-A Titanium ALIF system is an interbody fusion device indicated for use with autogenous bone graft in patients suffering from degenerative disc disease (DDD) at one or two contiguous levels from L2 to S1. The implants may be placed via a laparoscopic or an open anterior approach, and feature two anchor plates—housed within the three-dimensional (3D) printed titanium body—that are deployed into adjacent vertebrae to provide fixation. The use of supplementary fixation systems is also recommended.
ENZA-A Titanium ALIF has a roughened surface texture designed to encourage bone growth onto the cranial and caudal surfaces of the device. The upper and lower facets are deliberately designed with pores that average a large 500 microns in diameter, the optimal environment for bone ingrowth. In addition, the implant has multiple openings that allow large volumes of autogenous bone graft to be easily packed inside, further facilitating fusion. Proprietary inline instrumentation is used to insert the device, deploy the anchor plates, and lock it in place.
“ENZA-A leverages two of Camber Spine's highly innovative platform technologies,” said Daniel Pontecorvo, CEO of Camber Spine Technologies. “The vast interest and success of our first generation ENZA with Duo Presa anchor technology and our line of SPIRA products with Surface By Design inspired us to combine their defining attributes to create this next generation ENZA-A Titanium ALIF.”
Interbody devices are designed to replace the intervertebral disc of the spine, enhancing stability in the region while the spine fuses. Over time, the packed bone graft material is gradually replaced by natural bone. Fusion procedures also typically use a posterior fixation device to the associated level, since the surgeons will implant interbody devices from an anterior approach and flip the patient over to implant a posterior pedicle screw device. This combination increases fusion success.
Related Links:
Camber Spine Technologies
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Surgical System
Stealth AXiS
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Latest Surgical Techniques News
- Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
- New Approach Enables Customized Muscle Tissue Without Biomaterial Scaffolds
- Robot-Assisted Brain Angiography Improves Procedural Outcomes
- Brain Mapping Technology Enhances Precision in Brain Tumor Resection
- Handheld Robotic System Expands Options for Total Knee Surgery
- VR Experience Reduces Patient Anxiety Before Kidney Stone Procedure
- Injectable Mini Livers Offer Hope for Patients Awaiting Transplant
- Pulsed Field Ablation Technology Cleared in Europe for Persistent AFib
- AI-Powered Imaging Brings Real-Time Margin Clarity to Breast Cancer Surgery
- Minimally Invasive Device Safely Treats Challenging Brain Aneurysms
- Surgical Robot Makes Complex Liver Tumor Surgery Safer and Less Invasive
- Neurostimulation Implant Reduces Seizure Burden in Drug-Resistant Epilepsy
- Minimally Invasive Procedure Effectively Treats Small Kidney Cancers
- Fluorescence Probe Paired with Engineered Enzymes Lights Up Tumors for Easier Surgical Removal
- Novel Hydrogel Could Become Bone Implant of the Future
- Skull Implant Design Could Shape Surgical Outcomes
Channels
Artificial Intelligence
view channel
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read more
New AI Approach Monitors Brain Health Using Passive Wearable Data
Brain health spans cognitive and emotional functions and can fluctuate even in adults without diagnosed disease. Detecting early changes remains difficult in routine care and burdens specialty services... Read more
Critical Care
view channel
Automated IV Labeling Solution Improves Infusion Safety and Efficiency
Medication administration in high-acuity settings is often complicated by multiple concurrent infusions, making accurate line identification essential. In a 10-hospital intensive care unit study, 60% of... Read more
First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
Pulmonary hypertension is a progressive, life‑threatening disease that is frequently missed early because symptoms such as dyspnea are nonspecific and diagnostic delays can exceed two years.... Read more
Patient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
Health IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Business
view channel
GE HealthCare Leads Major European Initiative to Advance Cardio-Oncology Care
Cardiovascular complications are increasingly recognized among people undergoing or recovering from cancer treatment, driven by pre‑existing disease and the cardiotoxic effects of chemotherapy, radiotherapy,... Read more
